Posaconazole: A New Antifungal Weapon

Publisher： Bentham Science Publishers

E-ISSN： 1876-1038|6|3|204-219

ISSN： 1574-8871

Source： Reviews on Recent Clinical Trials, Vol.6, Iss.3, 2011-09, pp. : 204-219

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetics of a single dose of the antifungal posaconazole as oral suspension in subjects with hepatic impairment

By Moton Allen   Krishna Gopal   Ma Lei   O’Mara Edward   Prasad Pratapa   McLeod James   Preston Richard A.  

Current Medical Research and Opinion, Vol. 26, Iss. 1, 2010-01 ,pp. : 1-7

Informa Healthcare

Access to resources Recommend Favorite

Cost-effectiveness of primary antifungal prophylaxis with posaconazole versus itraconazole in allogeneic hematopoietic stem cell transplantation

By Sánchez-Ortega Isabel  

Journal of Medical Economics, Vol. 16, Iss. 6, 2013-06 ,pp. : 736-743

Informa Healthcare

Access to resources Recommend Favorite

Comparative survival and cost of antifungal therapy: posaconazole versus standard antifungals in the treatment of refractory invasive aspergillosis

By Herbrecht Raoul   Rajagopalan Srinivasan   Danna Robert   Papadopoulos George  

Current Medical Research and Opinion, Vol. 26, Iss. 10, 2010-10 ,pp. : 2457-2464

Informa Healthcare

Access to resources Recommend Favorite

TRAIL, a New Weapon against Neointimal Hyperplasia

By  

Cardiology, Vol. 123, Iss. 2, 2012-09 ,pp. : 94-96

Karger

Access to resources Recommend Favorite

Review of the New Delayed‐Release Oral Tablet and Intravenous Dosage Forms of Posaconazole

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 2, 2015-02 ,pp. : 208-219

John Wiley & Sons Inc

Access to resources Recommend Favorite